Penny that has potential to turn aroundIts a peeny stock, that usually I dont trade, but recently took position in it.
−51.16 M USD
0.00 USD
574.19 K
About Psyence Biomedical Ltd.
Sector
Industry
CEO
Neil Maresky
Website
Headquarters
Toronto
Founded
2021
FIGI
BBG01L71H227
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of PBM is 0.4200 USD — it has decreased by −8.72% in the past 24 hours. Watch Psyence Biomedical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Psyence Biomedical Ltd. stocks are traded under the ticker PBM.
PBM stock has fallen by −13.29% compared to the previous week, the month change is a −38.48% fall, over the last year Psyence Biomedical Ltd. has showed a −99.18% decrease.
PBM stock is 7.69% volatile and has beta coefficient of 1.65. Track Psyence Biomedical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Psyence Biomedical Ltd. there?
Today Psyence Biomedical Ltd. has the market capitalization of 293.11 K, it has increased by 3.35% over the last week.
Yes, you can track Psyence Biomedical Ltd. financials in yearly and quarterly reports right on TradingView.
PBM net income for the last quarter is 141.47 K USD, while the quarter before that showed −647.77 K USD of net income which accounts for 121.84% change. Track more Psyence Biomedical Ltd. financial stats to get the full picture.
No, PBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 10 employees. See our rating of the largest employees — is Psyence Biomedical Ltd. on this list?
Like other stocks, PBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Psyence Biomedical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Psyence Biomedical Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Psyence Biomedical Ltd. stock shows the sell signal. See more of Psyence Biomedical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.